NasaPharm (Private limited company)
NasaPharm is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 1019.084.374. It was founded on 23-01-2025. Its registered office is in Blegny. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € -21 265 and a loss of € 46 265. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk).
Information last updated on 07-10-2026.
Company information
Key figures of NasaPharm
| 2025 | |
|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -46 265 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -21 265 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 606 267 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -46 221 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - |
Financial estimate
Similar companies
Other companies in the same activity in Blegny.
| Company | Town |
|---|---|
| ORTHO MEDIC KURTH | 4671 Blégny |
| DOCTEUR LEJEUNE | 4671 Blégny |
| Médical Dr MASSET | 4671 Blégny |
| SUSTY WASTES SOLUTIONS | 4671 Blégny |
| SOCIETE MEDICALE MARIE PAPY | 4671 Blégny |
| FELIX CANIS | 4671 Blégny |
Frequently asked questions
Is NasaPharm still active? Yes. The Crossroads Bank for Enterprises lists NasaPharm as active.
What is the VAT number of NasaPharm? The VAT number of NasaPharm is BE 1019.084.374.
When was NasaPharm founded? NasaPharm was founded on 23-01-2025.
What is the address of NasaPharm? The current registered office of NasaPharm is Rue Thier du Ry 5, 4671 Blegny.
When did NasaPharm last file annual accounts? The latest annual accounts of NasaPharm were filed on 09-07-2026.
Is NasaPharm financially healthy? Addrly gives NasaPharm a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is NasaPharm profitable? The annual accounts of NasaPharm for 2025 show a loss of € 46 265.
What is the equity of NasaPharm? The equity of NasaPharm was € -21 265 at the close of the 2025 financial year.
Who are the directors of NasaPharm? The annual accounts of NasaPharm record 1 mandate. The name, role and dates are visible with a free account.
Can NasaPharm receive Peppol e-invoices? Yes. NasaPharm is registered on the Peppol network and can receive structured electronic invoices.
What does NasaPharm do? The main activity of NasaPharm is: Scientific research and development.